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Incidence of post-traumatic stress disorder (PTSD) ranges from 3 to 30% in individuals
exposed to traumatic events, with the highest prevalence in groups exposed to combat,
torture, or rape. To date, only a few FDA approved drugs are available to treat PTSD,
which only offer symptomatic relief and variable efficacy. There is, therefore, an urgent
need to explore new concepts regarding the biological responses causing PTSD. Animal
models are an appropriate platform for conducting such studies. Herein, we examined
the chronic behavioral and neurobiological effects of repeated unpredictable stress
(RUS) in a mouse model. 12 weeks-old C57BL/6J male mice were exposed to a 21day RUS paradigm consisting of exposures to a predator odor (TMT) whilst under
restraint, unstable social housing, inescapable footshocks and social isolation. Validity of
the model was assessed by comprehensive examination of behavioral outcomes at an
acute timepoint, 3 and 6 months post-RUS; and molecular profiling was also conducted
on brain and plasma samples at the acute and 6 months timepoints. Stressed mice
demonstrated recall of traumatic memories, passive stress coping behavior, acute
anxiety, and weight gain deficits when compared to control mice. Immunoblotting of
amygdala lysates showed a dysregulation in the p75NTR/ProBDNF, and glutamatergic
signaling in stressed mice at the acute timepoint. At 6 months after RUS, stressed
mice had lower plasma corticosterone, reduced hippocampal CA1 volume and reduced
brain-derived neurotrophic factor levels. In addition, glucocorticoid regulatory protein
FKBP5 was downregulated in the hypothalamus of stressed mice at the same
timepoint, together implicating an impaired hypothalamus-pituitary-adrenal-axis. Our
model demonstrates chronic behavioral and neurobiological outcomes consistent with
those reported in human PTSD cases and thus presents a platform through which to
understand the neurobiology of stress and explore new therapeutic interventions.
Keywords: PTSD, animal model, stress, HPA axis, corticosterone
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We have previously shown that exposure to a single footshock
with repeated exposure to TMT under restraint induced
acute PTSD-like behavior including anxiety-like behavior, social
avoidance and recall of fear memory in C57BL/6 mice (Ojo et al.,
2014). One of the major limitations of our previous model was
the lack of chronic and persistent behavioral and neurobiological
changes. The presence of acute symptoms after a traumatic
incident is not an accurate hallmark feature for PTSD diagnosis,
as they can be attributed to a normal adaptive stress response or
acute stress disorder (Flandreau and Toth, 2017). While acute
stress disorder and PTSD share a number of diagnostic criteria,
post-traumatic symptoms are primarily persistent (>1 month)
and in PTSD may also develop after a delay (DSM-5, 2013).
Therefore a chronic and long-lasting behavioral and biological
outcome in a mouse model is essential to more accurately
recapitulate the human PTSD experience.
To overcome this limitation in our earlier model, we
intensified our previous 21-day repeated unpredictable stress
(RUS) paradigm to include 10 unpredictable exposures
to TMT under restraint, 5-inescapable foot shocks, and
daily unstable social housing that was followed by social
isolation. The presence of chronic social stress in our model
is a unique feature in comparison with traditional CUS
paradigms.
We show that such repeated exposures to intense physical,
psychological, and psychosocial stressors resulted in PTSD-like
symptomology that includes reduced weight gain, acute anxiety,
and passive stress coping behavior in the forced swim test.
Stressed mice were also able to recall cued fear memory at
the acute timepoint, 3 and 6 months after RUS. Moreover,
exposure to stress resulted in biological responses typified by
neuroendocrine and HPA-axis abnormalities at a chronic time
point (6 months) after RUS. Mice exposed to stress also show
dysregulation in amygdaloid neurotrophic and glutamatergic
signaling, emphasizing the importance of these signaling
events as potential targets for modulation in treatment of
PTSD.

INTRODUCTION
Upon exposure to an acute stressor, the brain initiates “fight
or flight” responses involving the cardiovascular, endocrine
and immune systems to prepare the body for the possible
danger. After dismissal of the stressor, physiological homeostatic
mechanisms restore normal baseline functions. However, a single
exposure to a particularly severe traumatic stressor or prolonged
exposure to milder stressors, can lead to maladaptive responses
within the brain neurocircuitry regulating these homeostatic
mechanisms (Bonne et al., 2004; Sherin and Nemeroff, 2011; Roth
et al., 2012; Sambasivarao, 2013). Theses maladaptive responses
are involved in the pathophysiology of various stress-related
psychiatric illnesses such as anxiety disorders, post-traumatic
stress disorder (PTSD), and depression (McEwen, 2004).
In the United States, about 13% of women and 6% of men
who experience traumatic events will develop PTSD (Breslau
et al., 1999). Incidence of PTSD ranges from 3 to 30% in groups
exposed to specific traumatic incidents such as war, torture, or
rape (Kennedy, 2007). The symptoms of PTSD are marked by
the uncontrolled re-experiencing of traumatic events triggered
by intrusive memories, avoidance of traumatic cues, negative
alterations in cognition and mood, and dynamic fluctuation
in arousal and reactivity states (DSM-5, 2013). A diagnosis of
PTSD requires that these clusters of symptoms have to last for
at least 1 month to demonstrate clinical impact, and they have
to significantly influence the functional ability of the individual
in several domains. In the past decade, a growing body of
research has increased our knowledge about the pathophysiology
of PTSD; including hypothalamus-pituitary-adrenal (HPA) axis
dysregulation, increased sympathetic nervous system activity and
cellular/molecular alterations in the hippocampus, amygdala, and
prefrontal cortex. Despite these advancements, there are only
a few therapeutic strategies available, and these mainly include
psychotherapy and/or FDA-approved drugs designed for other
psychiatric conditions such as depression and anxiety (Krystal
et al., 2017). These treatments offer only symptomatic relief and
usually show limited efficacy, especially in the Veteran population
(Krystal et al., 2017).
To address this issue, several preclinical animal models have
been developed in efforts to achieve better understanding of the
underlying neurobiological abnormalities and to accelerate the
drug discovery process. Modeling PTSD in animals often involves
the use of intense stressors in either a single prolonged exposure,
such as the single prolonged stress (SPS) paradigms (Liberzon
et al., 1997), or in multiple unpredictable daily exposures such
as the chronic unpredictable stress (CUS) paradigms (Deslauriers
et al., 2018). While these models were successful in probing
PTSD-related phenotypes, studies exploring the long-lasting
behavioral effects of these paradigms in correlation with the
key biological outcomes of PTSD are lacking. In addition,
these models have limitations in modeling specific PTSD
phenotypes such as HPA axis dysregulation. For instance, CUS
and SPS paradigms often result in an increase in basal plasma
glucocorticoid levels after stress cessation, while they appear to be
low or unchanged in PTSD patients (Yehuda, 2001; Deslauriers
et al., 2018).
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MATERIALS AND METHODS
Animals
C57BL/6 male mice (aged 8–10 weeks) were purchased
from Jackson Laboratories (Bar Harbor, Maine) and housed
in standard cages under a 12-h light/12-h dark schedule
at ambient temperature. A 2-weeks habituation period was
allowed before the start of any experimental procedures.
All procedures were performed in accordance with OLAW
guidelines under an approved protocol by the Roskamp Institute
IACUC.

The 21-Day RUS Paradigm
Animals were randomly assigned to either a control group
(n = 15) or the stress group (n = 17). The 21-day RUS paradigm
is shown in Figure 1, and involved (i) daily unstable social
housing with an alternate congener; (ii) unpredictable repetitive
exposure to a psychological stressor of predator odor (TMT)
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FIGURE 1 | Study timeline and experimental procedures for the stress paradigm. Stress paradigm involved 21 days of daily unstable social housing with an alternate
congener (i), unpredictable repetitive exposures to danger-related predator odor (fox urine, TMT), while under a decapicone restrainer for 30 min (ii), and physical
trauma in the form of five repeated inescapable footshocks (iii). After 21 days of stress, animals in the stress group were singly housed until the end of the study (iv).
A battery of behavioral testing was conducted at an acute timepoint (1–14 days), 3 and 6 months after the last footshock. Brain tissue and plasma were collected
only at the acute timepoint (10 days) and 6 months after the last footshock.

while in a decapicone restrainer for 30 min in a dark room (1
exposure per day, 10 exposures within 21 days); (iii) physical
trauma in the form of five repeated inescapable foot-shocks; and
(iv) lack of social support (i.e., singly housed) post-traumatic
stress. Animals in the stress group were housed individually
after the 21 days, whereas animals in the control group were
housed in groups of 2–3 throughout the study. Animals in the
control group were never subjected to the decapicone restraint
or TMT exposure, but were exposed to the fear-conditioning
chamber for the same frequency and duration as the stressed
mice, without administration of foot shock or auditory cues.
4–5 animals per group were euthanized at 10 days after RUS
(acute timepoint) for molecular studies without receiving any
behavioral testing. The remaining animals per group received a
behavioral test battery at 1 day (acute timepoint) after RUS and
then were retested using a similar battery at 3 and 6 months
after RUS. Details about the timeline of the behavioral test
battery can be found in Supplementary Figure S1. After the last
behavioral experiment, all animals were euthanized and brain
and plasma were collected for molecular studies (6 months
timepoint).

Behavioral Testing
At least two baseline body weight measurements were taken
during the acclimation period and before administering the stress
paradigm. After exposure to the stress, body weight was measured
on a weekly basis for each mouse.

Fear Conditioning, Contextual, and Cued
Fear Testing
Fear conditioning was delivered in the form of five footshocks
on days 2, 4, 6, 9, and 12 of the stress exposures paradigm. This
involved placing animals in a shuttle box-chamber for 3 min, with
a pure tone (70 dB, 2.9 kHz) introduced during the last 30 s. At
the end of the auditory cue, animals received a single 1 mA of
uncontrollable/inescapable footshock for 4 s, and were allowed to
recover for 1 min in the same context before returning to their
home cages. The control group was allowed to explore the fearconditioning context for 3 min without introducing a tone or
electric shock. To determine retention of contextual/cued fear
memory animals were tested at the acute timepoint, 3 months,
and then 6 months after RUS. This involved placing animals in
the fear-conditioning spatial context for 3 min and measuring
the freezing response using automated video tracking system
(Ethovision; Noldus—Netherlands). Freezing responses were
calculated by Ethovision Software using the immobility time
(2.5% immobility threshold, 20 frames per second) (Ojo et al.,
2014). A cued memory test was conducted 1 h after the contextual
fear memory test, and involved placing animals in a novel context
for 3 min without the tone and a further 3 min with the tone.
Freezing response was measured throughout the entire 6 min
period.

TMT
Trimethylthiazoline (TMT, SRQ Bio, Sarasota, FL, United States)
is a component of fox urine, which we and others have previously
used as a predator odor stressor (Endres and Fendt, 2009; Janitzky
et al., 2015). TMT was diluted 1:10 (v/v) in double distilled water
before being used as a predator odor stressor. 50 µl of 10%
TMT were dispensed on a tissue paper then placed next to the
restrained animal.
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was placed in the middle chamber and left to explore the three
chambers for 10 min. The time spent in the Stanger1 chamber
versus the empty cage is used to evaluate social interaction of
the test subject. In the second session, another intruder mouse
(Stranger2) was placed in the second cage along with the previous
intruder mouse (Stranger1) still held in the first cage, and the test
subject was allowed to freely explore both chambers for 10 min.
The time spent in the Stanger2 versus Stranger1 chamber was
used to evaluate the social memory of the tested animal.

Open Field Test
Anxiety and sensorimotor behavior were further assessed by the
open field test (Hall and Ballachey, 1932). This test was conducted
in a circular maze (120 cm diameter) setup in a dim lit room (80
lux). Animals were placed in the center of the maze and the time
spent in a predefined center zone and around the walls of the
maze was recorded over a 15 min trial.

Elevated Plus Maze
Anxiety behavior was evaluated using the elevated plus maze
(EPM) (Pellow et al., 1985). The apparatus consists of two open
and two closed arms forming a plus shape. The arms are elevated
70 cm from the floor. Each mouse was placed on the junction
of the four arms of the maze, facing the open arm. The mouse
was allowed to freely explore the maze for 5 min in a dark light
(∼1 lux). The percentage of time spent in the open arms was
calculated using Ethovision video tracking system. Animals were
retested in a different room at 6 months after RUS.

Enzyme-Linked Immunosorbent Assay
(ELISA)
To obtain blood specimens, animals were anesthetized with
isoflurane, and approximately 500 µL of blood were collected into
EDTA tubes by cardiac puncture immediately prior to euthanasia.
Samples were centrifuged at 3000 × g for 3 min, and plasma
samples (clear supernatant fraction) were flash frozen in liquid
nitrogen and stored at −80◦ C. Plasma Corticotropin-releasing
hormone (CRH) levels were measured using an ELISA purchased
from Life-Span Biosciences (Seattle, WA, United States). The
Adrenocorticotropic Hormone (ACTH) ELISA was purchased
from Cloud-Clone Corp. (Katy, TX, United States). Tissue and
plasma corticosterone levels were measured using an ELISA from
Arbor Assays (Ann Arbor, MI, United States) and tissue brainderived neurotrophic factor (BDNF) levels were measured using
an ELISA from Boster Bio (Pleasanton, CA, United States). ELISA
kits were used as per manufacturers’ instructions.

Forced Swim Test
The test was performed in a cylindrical container (20 cm
height × 20 cm diameters) filled with water at room temperature.
Animals were placed in the container for 6 min with video
recording from the top. The time spent floating (neither
swimming nor climbing) was calculated using Ethovision
immobility parameter (7.5% immobility threshold, 20 frames
per second) as a measure of depression-like behavior. The
immobility time measured by our automated detection settings
was comparable to manually calculated floating times by a
blinded observer (data not shown).

Brain Tissue Preparation and Western
Blotting
Brains from six animals per group were used for biochemical
analysis while the brains form the remaining animals were used
for hippocampal volume estimation (histopathology). Western
blot experiments were conducted as described previously (Ojo
et al., 2016). In brief, six animals from the stress group and
six control animals were used for all western blot and ELISA
experiments from brain tissue. Tissue was collected following
transcardial perfusion by gravity drip with phosphate buffered
saline (PBS). Both hemispheres were extracted and dissected into
multiple regions (hippocampus, amygdala, and hypothalamus);
these were flash frozen in liquid nitrogen and kept
at −80◦ C.
For western blotting analyses, the hippocampi or amygdala
from both hemispheres were homogenized in 200 µL of
M-PER protein extraction reagent containing proteinase and
phosphatase inhibitors (Thermo fisher) using a probe sonicator.
Samples received 2-s long sonication pulse followed by
incubation on ice for 10 s, this process was repeated three times.
Homogenized samples were spun in a centrifuge at 15,000 × g
for 10 min and tissue supernatants were collected. Supernatant
fractions were denatured at 99◦ C by boiling in Laemmli buffer
(Bio-Rad) containing DDT. Samples were then subsequently
resolved on 4–15% gradient polyacrylamide criterion gels
(Bio-Rad). After electrotransferring, polyvinylidene difluoride
membranes were blocked in 5% milk made in Tris-buffered saline
and subsequently immunoprobed for different brain-specific

Radial Arm Water Maze (RAWM)
The RAWM test for spatial learning and memory was conducted
as described by Park et al. (2008) (Soliman et al., 2010). In brief,
the test was conducted in a RAWM pool (120 cm diameter and
30–40 cm height), containing six swim paths extending from an
open central arena. A hidden escape platform was placed beneath
the end of the target arm and each of the arms was marked with
a unique visual cue. Animals were trained for 5 days with 12
trials per day to locate the hidden goal arm. Each trial lasted for
60 s. Each entry to a wrong arm was scored as a memory error.
The number of errors per block trial, across the entire length of
the training session was recorded using a video-tracking system
(Ethovision, Noldus—Netherlands). All animals were subjected
to the test at three time points after the traumatic stress (i.e.,
2 weeks and 3 and 6 months after traumatic stress).

Social Interaction and Novelty
Recognition Tests (Three-Chamber Test)
The three-chamber test was used to evaluate social behavior.
The testing apparatus consists of a rectangular box with three
chambers separated by two doors. Each of the outer chambers
contains a cage enclosure. The mice were habituated to the testing
box for 5 min prior to testing. Testing occurred in two sessions. In
the first session, a new intruder mouse (Stranger1) was placed in
one cage, while the other cage was left empty. The tested mouse
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software package. Digital images were captured electronically and
the boundaries of the total dorsal hippocampal compartment
and its subfields (DG, CA1, and CA2/CA3) were digitally
outlined on each section from the series of sagittal sections of
the right hemisphere. For each animal, the total volume of the
right hippocampus and its subfields were subsequently derived
by multiplying the calculated total surface area by the mean
distance between the series of sections. Data are expressed as
mean volume (in mm3 ) ± SEM.

primary antibodies overnight (Supplementary Table S1). After
three washing steps, membranes were probed with horseradish
peroxidase-linked secondary antibodies (Supplementary Table
S1). Anti-GAPDH antibody was used as a housekeeping gene
to quantify the amount of proteins electrotransferred, and signal
intensity ratios were quantified by chemiluminescence imaging
with the ChemiDocTM XRS (Bio-Rad).

Multiplex Enzyme-Linked
Immunosorbent Assay (ELISA)
Levels of nine cytokines; interferon γ (IFN-γ), interleukin
(IL)-1β, IL-2, IL-4, IL-6, IL-10, IL-12p70, IL-13, and tumor
necrosis factor α were measured from a single plasma sample
(12.5 µL) using the MSD proinflammatory Panel I multiplex
assay (MesoScale Discovery, Gaithersburg, MD, United States).

Statistical Analysis
The relationships between stress and control animals for Western
blotting, ELISA, and neurobehavioral data were assessed using a
t-test predefined criterion of p < 0.05 to assess group differences,
while experiments examining stress effects over time were
assessed using a RM-ANOVA. Pearson correlation and Spearman
correlation were used for parametric and non-parametric data
sets, respectively. The choice of the appropriate statistical test
was made after assessment of normal distribution using the
Shapiro–Wilk normality test. All analyses were performed with
Graph Pad prism version 7.0a statistical software (La Jolla, CA,
United States). Statistical outliers were identified using Grubbs’
test and excluded.

Neuropeptide Magnetic Bead Panel
From Hypothalamus
Levels of six neuropeptides (α-MSH, β-Endorphin, Neurotensin,
Orexin A, Oxytocin, Substance P) were measured in the
hypothalamus using MILLIPLEX MAP Rat/Mouse Neuropeptide
Magnetic Bead Panel. The following procedures were
implemented in order to extract neuropeptides from the
hypothalamic tissue. Each dissected hypothalamus was dissolved
in 200 µL deionized water and homogenized using a probe
sonicator on ice. Immediately after homogenization, 100 µL of
the hypothalamus lysates were mixed with 200 µL acetonitrile
and incubated for 10 min at room temperature then centrifuged
at 17,000 × g for 5 min. Clear supernatants were collected and
dried using speed-vac without sample heating then solubilized in
100 µL of the manufacture’s assay buffer. The rest of multiplex
assay steps were carried out as instructed by the manufacturer’s
guide. Phosphatase and protease inhibitors were added to the
remainder of the original lysates and stored for western blot
experiments.

RESULTS
Mice Exposed to the 21-Day Stress
Paradigm Show Attenuation of
Bodyweight Gain and Anxiety-Like
Behavior Immediately After Stress
Stress is usually associated with changes in bodyweight and
food intake (Harris, 2014). Therefore, we obtained the weekly
bodyweight for each mouse to examine the effects of the RUS
paradigm (Figure 2A). Stressed mice showed reduced weight
gain in the first 3 weeks of stress (RM-ANOVA: interaction
F (4,116) = 12.54, p < 0.0001, with the Sidak post hoc test)
compared to their unexposed group. The changes in bodyweight
are mainly driven by an intense decrease in their growth
rate during the first week of stress (RM-ANOVA: interaction
F (3,87) = 10.58, p < 0.0001, with the Sidak post hoc test,
Figure 2B). The bodyweight deficits in the stressed mice persisted
until 2 months after stress (t-test: t (20) = 2.54, p = 0.02) but by
3 and 6 months post-stress there are no significant differences
in bodyweight between groups (Supplementary Figure S2). In
addition, stressed mice showed an anxiety-like behavior as
evident by reduced center zone entries per 3 min time bins
(RM-ANOVA: stress effect F (1,18) = 27.87, p < 0.0001, with the
Sidak post hoc test) and throughout the entire 15 min (t-test:
t (18) = 5.174, p < 0.0001) in the open field test (Figures 2C,D)
at the acute timepoint. However, assessment in the EPM in
the same timepoint showed no significant differences between
groups in the open arm duration (t-test: t (18) = 1.8, p = 0.083,
Figure 2E) or open arm entries (t-test: t (18) = 1.8, p = 0.99,
Figure 2F).

Hippocampal Volume Estimation
Five control animals and six stressed animals where used for
volume estimation from the hippocampus using Cavalieri
principal. At 6 months after last stress exposure, mice were
anesthetized with 3% isoflurane and transcardially perfused
with a 4% paraformaldehyde PBS solution. Brain hemispheres
were post-fixed overnight in 4% paraformaldehyde-PBS
solution. The volume of the right hippocampus as guided by
bregma coordinates (−0.94 to −3.28 mm) was determined by
quantitative light microscopy using the Cavalieri method as
described elsewhere (Ojo et al., 2014). In brief, sagittal sections
from the extent of the right hippocampus of each animal (taking
every 20th serial section) were mounted onto superfrost plus
slides. An average of 10–15 sections were collected per animal.
Mounted sections were air-dried and stained with a solution of
0.1% cresyl fast violet (Tedpella, Reading, CA, United States) and
were viewed at low magnification using a DP72 digital camera
attached to a motorized Olympus BX63 digital photomicroscope
(Olympus, Center Valley, PA, United States). Analyses were
carried out blind and were made via the Cell SENS Olympus
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FIGURE 2 | Effect of RUS on bodyweight gain and anxiety-like behavior. During the 21-day stress paradigm, stressed mice showed a reduction in body weight gain
when compared to control mice (A). Growth rate was significantly lower only during and after the first week of stress (day 7) (B). Exposure to stress increased
anxiety-like behavior at the acute timepoint as evident by reduced center zone entries per a 3-min time bin (C) and in the total 15 min (D) in the open field test. No
significant changes were observed in the EPM open arm time (E) and entries (F) at the acute timepoint. Data in (A,B) was analyzed using repeated measures
Two-Way ANOVA followed by post hoc Tukey’s test (n = 14–17), while data in (C–F) were analyzed using a student t-test (n = 8–9). Asterisks denote statistical
significance as follows: ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001.

Stressed Mice Recall Fear Memory and
Show Passive Stress Coping Behavior at
6 Months After RUS

examined at 6 months after RUS using the forced swim test and
the EPM, respectively. As depicted in Figures 3G,H, stressed
animals showed negative stress coping behavior as evident
by increased immobility time in the forced swim test (t-test:
t (20) = 2.5, p = 0.02, Figure 3H). No significant differences were
observed between control and stressed mice at 3 and 6 months
after RUS in the number of open arm entries in the EPM
(p > 0.05; Supplementary Figure S3A and Figure 3I) or center
zone entries in the open field test (p > 0.05; Supplementary
Figure S3B). It is important to note that the performance of
mice in the EPM test and the suitability of the EPM and Open
field for retesting is questionable (Walf and Frye, 2007; Hussin
et al., 2012). Control mice in the EPM always performed poorly
(spending only few seconds in the open arms) which reduced
the window for detecting a significant effect between sham and
stressed mice. Additionally, although some studies suggested
changing the retesting room and separating the trials by 4 weeks
to improve retesting reliability (Schneider et al., 2011), our data
indicated that control mice show fewer entries to the open arms of
EPM and center zone of the Open Field upon retesting at different
rooms 3 and 6 months after RUS (Supplementary Figures S3A,B).
Contextual memory retrieval is thought to be a hippocampaldependent task (Maren and Holt, 2000). Since stressed mice
were able recall cued fear memory, but not contextual fear

Fear conditioning using electric footshocks was used as a
stressor in the RUS paradigm and also as a tool to evaluate
the recall of contextual and cued fear memory responses (Ojo
et al., 2014). Stressed mice showed a significant increase in
their freezing (immobility time) when placed in the same
trauma context at the acute timepoint (t-test: t (21) = 8.4,
p < 0.0001, Figure 3A). However, stressed mice were not
able to recall contextual fear memory when examined at 3
and 6 months after RUS (Figures 3B,C, p > 0.05). We also
examined recall of cued fear memory at the same timepoints.
Mice were placed in a novel context for 3 min, and then
exposed to a trauma related cue (auditory tone) lasting an
additional 3 min. While all animal groups showed minimal
freezing during the first 3 min in the novel context (without a
tone), stressed animals showed an increased % freezing upon
tone introduction at the acute timepoint (Two-way ANOVA,
interaction F (1,40) = 111.8, p < 0.0001, Figure 3D), 3 months
(Two-way ANOVA, interaction F (1,40) = 8.7, p < 0.0052,
Figure 3E) and 6 months (Two-way ANOVA, interaction
F (1,40) = 5.4, p < 0.025, Figure 3F) after RUS. Chronic changes
in stress-coping strategies and anxiety-like behavior were also
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FIGURE 3 | Recall of contextual and cued fear memory at the acute timepoint, 3 and 6 months after RUS. Stressed animals recalled contextual fear memories only
at the acute timepoint as evident by increased freezing time compared to controls at the acute timepoint (A), but not at 3 months (B) or 6 months (C) after RUS.
Panels (E–G) depict% freezing scores in the first minute of the cued memory test in absence and presence of a cue (tone) at the acute, 3- and 6-month timepoints,
respectively. There was no significant freezing for all treatment groups when tested in a new context without cues (no tone) at all timepoints (D–F). After tone
introduction, RUS mice showed a significant increase in % freezing at the acute timepoint, 3 and 6 months after RUS (D–F). Stressed mice displayed increased
immobility time in minutes 4 and 6 of the FST when compared to a control group (G). Average immobility time in the last 4 min was increased in stressed mice
compared to the control group (H). RUS didn’t alter open arm entries in the elevated plus maze test at 6 months after stress. Data in (A–C,H,I) were analyzed using
a student t-test (n = 6–12), while data in (D–F) were analyzed using repeated measures Two-Way ANOVA followed by post hoc Sidak test (n = 10–12). Asterisks
denote statistical significance as follows: ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001.

to stress showed significantly lower plasma corticosterone levels
(t-test: t (21) = 2.9, p = 0.009, Figure 4A) compared to control
mice. Similarly, ACTH levels were significantly lower in stressed
mice compared to controls (t-test: t (14) = 2.3, p = 0.04,
Figure 4B). No significant change was seen in plasma CRH at
6 months (p > 0.05, Figure 4C). We subsequently examined
glucocorticoid signaling in the hypothalamus by measuring
the expression levels of glucocorticoid receptors (GRs) and
regulatory proteins (Figures 4D–H). While there was no change
in expression levels of GR, mineralocorticoid receptor (MR), or
CRH levels, the levels of FK506 binding protein 51 (FKBP51)
were downregulated in the hypothalamus of stressed mice relative
to controls (t-test: t (9) = 2.4, p = 0.042, Figures 4D,G). To
explore the relationship between abnormalities in the HPA axis
function and behavioral outcomes in our model, we assessed the
statistical correlation between individual mouse corticosterone
plasma levels and their corresponding neurobehavioral scores in
both control and stress groups. We found a significant negative
correlation between plasma corticosterone levels and freezing
scores in the cued fear memory test (Spearman correlation:
r = −0.749, p = 0.001, Figure 4I) and the immobility time in
the forced swim test (Pearson correlation: r = −0.63, p = 0.0022,

memory at 3 and 6 months after RUS, we examined the effect
of stress on other hippocampal-related tasks such as social
memory and spatial learning. Mice exposed to RUS did not
show any impairment in social memory at the acute timepoint,
3 months or at 6 months after RUS when tested using social
novelty recognition tests (p > 0.05; Supplementary Figure
S4). Our findings in the social memory test at the chronic
timepoints are inconclusive because control mice did not show
any preference to the novel mouse (Stranger2), possibly due to
retesting (Supplementary Figure S4B). There was, however, no
impairments in spatial learning and memory in stressed animals
at any timepoint when tested using the RAWM (p > 0.05;
Supplementary Figure S5).

Stressed Mice Display Lower Plasma
Corticosterone Levels 6 Months After
RUS; Suggesting Blunted HPA-Axis
Reactivity
In order to examine the effect of stress on the HPA axis, baseline
plasma corticosterone levels were measured at the end of the
light cycle 6 months after RUS. We found that mice exposed
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FIGURE 4 | Effect of stress on HPA axis regulation at 6 months after RUS. Mice exposed to stress showed lower plasma levels of corticosterone (A) and ACTH (B),
but not CRH (C) when compared to a control group at 6 months after RUS (n = 8–12). Representative western blot images for markers of glucocorticoid signaling in
the hypothalamus (D). Quantification of mineralocorticoid Receptor (E), glucocorticoid receptor (F), FKBP5 (G), and CRH (H) levels in the hypothalamus (n = 5–6).
Only the levels of FKBP5 (G) were significantly reduced after RUS. Plasma corticosterone levels were inversely correlated with the% freezing scores in the cued fear
memory test (I) and the immobility time in the forced swim test (J) (n = 21). There was a positive correlation between% freezing scores in the cued fear memory test
and the immobility time in the forced swim test (K). Each solid black triangle represents an animal in the stress group, while white circles represent control animals.
Asterisks denote statistical significance as follows: ∗ p < 0.05; ∗∗ p < 0.01.

Figure 4J). Furthermore, cued fear memory freezing scores
correlated positively with the immobility time in the forced swim
test (Pearson correlation: r = −0.479, p = 0.0278, Figure 4K).
Previous studies have suggested interplay between
the endocrine and inflammatory/immune systems in the
pathophysiology of depression (Griffin et al., 2014) and PTSD
(Griffin et al., 2014), owing partly to the immunoregulatory role
of corticosterone. To examine the effect of our RUS paradigm on
the peripheral immune system, we evaluated the levels of plasma
cytokines at 6 months after stress. We found a twofold increase
in plasma levels of pro-inflammatory IL-1β (t-test: t (8) = 2.4,
p = 0.04, Table 1) and IFN-γ (t-test: t (7) = 3.9, p = 0.006, Table 1),
while the levels of other cytokines were not significantly altered
(Table 1).
As the hypothalamus secretes numerous neuropeptides that
regulate several autonomic functions implicated in regulating
neurocircuitry pathways involved in stress management, we
measured the expression levels of various neuropeptides in the
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TABLE 1 | Effect of stress on plasma cytokines at 6 months after RUS.
Cytokine

Fold change$ ± SD

n

Time after stress (months)

1.97 ± 0.26

0.04∗

5

6

1.02 ± 0.82

0.88

5

6

IL-1β∗∗

1.94 ± 0.07

0.006∗∗

5

6

IL-2

1.15 ± 0.27

0.688

5

6

IL-5

0.84 ± 0.57

0.613

5

6

IL-6

1.25 ± 1.37

0.431

5

6

IL-10

0.83 ± 1.30

0.132

5

6

IL-12

1.65 ± 4.96

0.276

5

6

IFN-γ∗
TNFα

p-Value

$ Plasma

cytokines levels in stressed animals relative to controls ± SD. Asterisks
denote statistical significance as follows: ∗ p < 0:05; ∗∗ p < 0:01.

hypothalamus using a magnetic bead multiplex assay. As shown
in Figure 5, there was no significant difference in the expression
levels of Oxytocin, β-endorphin, Neurotensin, α-MSH, and
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FIGURE 5 | Exposure to stress elevates (A) Orexin-A levels in the hypothalamus. Magnetic beads multiplex assay showed an increase in the hypothalamic levels of
Orexin-A at 6 months after RUS. No significant changes were observed in the levels of Oxytocin (B), β-endorphin (C), Substance P (D), α-MSH (E), and Neurotensin
(F). Data in Figure 5 were analyzed using a student t-test (n = 5–6). Asterisks denote statistical significance as follows: ∗ p < 0.05.

Substance P (Figure 5, p > 0.05). Interestingly, Orexin-A levels
were significantly elevated in stressed mice compared to controls
(t-test: t (10) = 2.437, p = 0.035, Figure 5A).

lysates. BDNF levels were downregulated in mice exposed to RUS
(t-test: t (9) = 3.55, p = 0.006, Figure 6D), while the levels of
other markers such as Post Synaptic Density protein 95 (PSD95),
CAMKII, NGF, TRKB, ProBDNF, and NMDA receptors were
not significantly altered after RUS (p > 0.05; Supplementary
Figure S6). Interestingly, CRH levels were elevated in animals
exposed to stress (t-test: t (10) = 2.4, p = 0.037, Figure 6I) at
6 months. Moreover, we did not observe any significant change
in glucocorticoid signaling receptors (GR and MR) or related
binding proteins (FKBP51) at 6 months (Figures 6E–I).

Effect of Stress on the Hippocampus at
6 Months After RUS
The hippocampus is prone to negative consequences of stress
(McEwen et al., 2016) and it is postulated that corticosteroids
are primary mediators of these stress effects (Roth et al.,
2012). Consistent with our plasma findings, corticosterone
levels were also reduced in the hippocampal tissue lysates
of stressed mice compared to controls (t-test: t (10) = 2.34,
p = 0.044, Figure 6A). To further examine the chronic effect
of RUS on the hippocampus, we estimated the volume of
the hippocampus and its subfields and measured the levels of
a number of synaptic plasticity markers. Using the Cavalieri
stereology principle for volume estimation, we found that the
volume of the CA1 region of the dorsal hippocampus (t-test:
t (9) = 2.34, p = 0.044, Figure 6B) was significantly reduced
in stressed animals compared to controls at 6 months after
stress. In addition, there was a trend toward reduced total dorsal
hippocampus volume (t-test: t (9) = 2.13, p = 0.061, Figure 6C)
in stressed animals, and no significant change in CA2 and
CA3 or Dentate gyrus regions (p > 0.05, Figure 6B). We then
examined the expression levels of notable markers/mediators
of neuroplasticity using immunoblot analysis of hippocampal
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Effect of Stress on Markers of
Neuroplasticity in the Amygdala
The amygdala is associated with emotional learning and cued
fear memory and is also prone to negative consequences of
stress (McEwen et al., 2016). Therefore, we probed for the
levels of a number of markers associated with neuroplasticity
using immunoblotting. No significant changes were observed
in amygdala lysates at 6 months after stress (p > 0.05;
Supplementary Figure S7). However, we observed that lysates
from the acute timepoint showed significant changes in several
markers associated with neuroplasticity. As shown in Figure 7,
there was a significant reduction in the levels of ProBDNF (ttest: t (7) = 2.64, p = 0.034, Figure 7E) and its signaling receptor,
P75NTR (t-test: t (7) = 4.02, p = 0.0052, Figure 7D). In addition,
levels of NMDA receptor type1 were reduced (t-test: t (7) = 6.15,
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FIGURE 6 | Effect of stress on the hippocampus at 6 months after RUS. Effect of stress on the volume of the dorsal hippocampus (A) and the volume other
hippocampal regions (B). Stress resulted in a volume reduction only in the CA1 region (B). Hippocampal BDNF (C) and corticosterone (D) levels were also reduced
at 6 months after stress. Representative western blot images for markers of glucocorticoid signaling in the Hippocampus (E). Quantification of mineralocorticoid
receptor (F), glucocorticoid Receptor (G), FKBP5 (H), and CRH (I) levels in the hippocampus at 6 months after RUS. Only the levels of CRH (I) were significantly
reduced after RUS. Data were analyzed using a student t-test (n = 5–6). Asterisks denote statistical significance as follows: ∗ p < 0.05; ∗∗ p < 0.01.

FIGURE 7 | Effect of stress on the amygdala at the acute timepoint. Representative western blot images from amygdala lysates for neurotrophic markers, NMDA
receptors, and other synaptic plasticity markers are shown in (A,F,K), respectively. Quantification of western blot images of TRKB (B), P75NTR (D), ProBDNF (E),
and NMDAR2B (G), NMDAR2A (H), NMDAR1 (I), PSD95 (J), CAMKII (L), and pNF-κB/NF-κB (M) levels in the amygdala at the acute timepoint. No change in
amygdala BDNF levels after RUS at the acute timepoint (C). All Data were analyzed using a student t-test (n = 5–6). Asterisks denote statistical significance as
follows: ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001.
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FIGURE 8 | A summary of stress effects on the amygdala, hippocampus, and HPA axis at different timepoints after RUS.

p = 0.0003, Figure 7I), including downstream signaling kinase,
CAMKII (t-test: t (7) = 4.5, p = 0.003, Figure 7L) and spine density
protein marker, PSD95 (t-test: t (7) = 3.17, p = 0.016, Figure 7J) in
animals exposed to stress compared to controls.
No significant changes were observed in the amygdalar levels
of BDNF or its receptor, Trkb (p > 0.05, Figures 7B,C); neither
were there any changes in other NMDA receptor subunits such
NMDAR2B and NMDAR2A (p > 0.05, Figures 6G,H) or in the
ratio of phosphorylated nuclear factor κB to nuclear factor κB
(pNF-κB/NF-κB). A summary of the findings presented in this
study is depicted in Figure 8.

6 months after RUS (Figures 4A, 6B) support the construct
validity of our model.
Because we have utilized a prolonged unpredictable repeated
stress paradigm in this study, a caveat of this work is the ability
to distinguish between PTSD and other related neuropsychiatric
conditions such as depression. Although there is a considerable
symptom overlap between PTSD and depression, the nature of
HPA axis dysregulation is markedly different (Schöner et al.,
2017). Increased plasma cortisol levels is a common finding in
human patients with depression (Palazidou, 2012; Gold et al.,
2015). In animal studies, exposure to chronic mild to moderate
stress is commonly used to study depression (McEwen, 2004;
Strekalova et al., 2004). For example, CUS paradigms involve
random, unpredictable exposure to variable daily stressors such
as restraint, cage tilting and shaking for 4–8 weeks. CUS models
typically show anxiety, depression-like behavior and increased
plasma corticosterone levels at one, 6 and 18 days after stress
cessation (Monteiro et al., 2015; Abd El Wahab et al., 2018).
Interestingly, C57BL/6 mice appear to be more resilient to CUS
compared to other mouse strains and longer stress durations
are usually needed to show depression-like behavior (Monteiro
et al., 2015). Blunted HPA axis reactivity to acute stressors has
been reported in repeated immobilization (Liberzon et al., 1997;
Harvey et al., 2006), social defeat (Beitia et al., 2005), and predator
exposure models (Zoladz et al., 2015). In addition, social isolation
has been linked to reduced plasma baseline corticosterone levels
in mice (Arndt et al., 2009; Martin and Brown, 2010), therefore
the incorporation of repeated stress and social isolation to our
RUS paradigm may have contributed to the decreased basal
corticosterone levels in our model as compared to the traditional
CUS paradigms. Future studies including earlier timepoints and
control groups receiving CUS and SPS are needed to explore

DISCUSSION
In this study, we assessed the chronic neurobehavioral,
neuroendocrine, and neurobiological consequences of a RUS
paradigm in mice. The purpose of our study was to develop
a mouse model of stress with relevance to PTSD that
demonstrates chronic behavioral deficits (face validity) with
validated pathophysiological measures (construct validity). Using
a battery of behavioral tests, we showed that animals exposed
to RUS demonstrate traits similar to the human condition;
particularly acute anxiety (Figures 2C,D), recall of traumatic
memory cues (Figures 3D–F), and negative alterations in stress
coping strategies (Figures 3G,H) at 6 months after RUS.
Blunted HPA axis responsiveness (Yehuda et al., 1993;
Yehuda, 2001) (measured as lower cortisol levels compared to
control subjects) and reduced hippocampal volume (Bremner
et al., 1995; Levy-Gigi et al., 2013) have been frequently
reported in PTSD human subjects. Our findings of lower plasma
corticosterone levels and reduced hippocampal CA1 volume
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in a number of psychological disorders such as depression
(Deslauriers et al., 2018) and PTSD (Gill et al., 2009; Wang
et al., 2017). Specifically, IL-1β levels were elevate in combat
PTSD males compared to non-traumatized controls (Spivak et al.,
1997). In addition, plasma levels of IFN-γ were elevated in
PTSD veterans when compared to a healthy control group (Zhou
et al., 2014). The low baseline corticosterone levels in our model
may underlie a failure of the HPA axis to regulate immune
response and therefore explain the elevation in plasma cytokine
levels which may contribute toward a primed inflammatory state
(Table 1).
Exposure to severe traumatic stress is associated with reduced
hippocampus volume (Kim et al., 2015; Ahmed-Leitao et al.,
2016; Fragkaki et al., 2016; McEwen et al., 2016). A recent largescale multisite neuroimaging study involving 1868 subjects found
smaller hippocampi volumes in subjects with PTSD compared
to trauma-exposed controls (Logue et al., 2018). In addition, a
meta analysis of magnetic resonance imaging studies of adults
with PTSD found hippocampal volume reductions in subjects
with PTSD (n = 846) compared to traumatized controls (n = 624)
with the left-hippocampi showing greater reductions (O’Doherty
et al., 2015). For the majority of these PTSD subjects, MRI
scans were taken more than 10 years since the last trauma
(O’Doherty et al., 2015). However, a number of studies have
suggested that smaller hippocampal volume is a risk factor for
the development of PTSD rather than a trauma consequence
(Gilbertson et al., 2010; van Rooij et al., 2015). In animals, chronic
restraint stress has been shown to selectively reduce hippocampal
volume in rats (when compared to the pre-stress volume)
(Gilbertson et al., 2010). A recent study showed that chronic
unpredictable restraint stress or diminished adult neurogenesis
can contribute to reduced volumes of both dorsal and ventral
hippocampus in rats (Schoenfeld et al., 2017). Our results showed
a trend toward reduction in the dorsal hippocampus, and a
statistically significant reduction in the CA1 of the right dorsal
hippocampus 6 months after exposure to RUS. The pyramidal
cells of the CA1 subfield of the dorsal hippocampus is involved
in processing and retrieval of visuospatial cues or memories (Ji
and Maren, 2008), and it relays information received from other
hippocampal subfields to neocortical areas for higher cognitive
processing. The impact of stress on different subfield regions
within the hippocampus remains inconclusive. A study on rats
found a reduction in the volume of CA1 after 2 weeks of
chronic unpredictable mild stress, while a number of studies
found a reduction in the CA3 volume after CUS (McEwen et al.,
2016; Morey et al., 2016; Schoenfeld et al., 2017). Impairments
within the hippocampal neurocircuitry could contribute toward
abnormalities in the encoding, retrieval and processing of
memory in PTSD pathobiology; specifically with regard to the
ability to discriminate between safe and aversive contexts, i.e.,
fear generalization. Additional experiments in this current model
will be required to explore this further using context specific
cues that are needed to evaluate fear generalization. In addition,
examining the effect of RUS on fear memory recall compared to
a control group receiving only fear conditioning is necessary to
understand the effect of extinction on recall of contextual and
cued fear memories in the current model.

the differences between these paradigms and RUS. In contrast to
depression, PTSD patients typically show lower plasma cortisol
levels compared to healthy controls (Yehuda et al., 1993; Yehuda,
2001). While one possible interpretation of our behavioral results
is stress induced depression, the blunted HPA axis reactivity is
consistent with observations in PTSD, and thus the lower plasma
corticosterone levels observed at 6 months after RUS suggest that
our model has more relevance for PTSD.
The blunted HPA axis response in PTSD is thought to be
due to increased negative feedback sensitivity via enhanced GR
responsiveness (Yehuda et al., 2009; Hartmann et al., 2012;
Schöner et al., 2017). FK506 binding protein 5 (FKBP5) is
thought to be a regulator of GR sensitivity. Under normal
conditions, cortisol binds GR in the cytoplasm and results in
GR dissociation from chaperone proteins such as heat shock
90 and FKBP5 inside the cytosol, resulting in the transport of
GR into the nucleus through openings in the nuclear pores,
the subsequent activation of GR transcriptional activity and
increase of regulatory proteins to promote negative feedback
mechanisms. In contrast, with PTSD, less free cortisol is available
to bind GR, which in turn results in downregulation of negative
feedback regulatory proteins such as FKBP5 (Girgenti et al.,
2017b). Interestingly, FKBP5 gene knockout mice show increased
GR sensitivity resulting in decreased corticosterone levels after
restraint stress (Touma et al., 2011). Previous reports have shown
that FKBP5 expression levels are reduced in white blood cells and
brains of trauma-exposed patients (Yehuda et al., 2009; Levy-Gigi
et al., 2013; Young et al., 2015). FKBP5 levels were also reduced
in the prefrontal cortex of post-mortem PTSD human subjects
(Girgenti et al., 2017a). In addition, FKBP5 gene polymorphism
and epigenetic methylation patterns are associated with GR
sensitivity and have also been linked to early-childhood trauma
and risk of PTSD (Yehuda et al., 2009; Zovkic and Sweatt,
2012). We found the levels of FKBP5 to be reduced in the
hypothalamus of RUS mice the 6 months timepoint, supporting
a central role for FKBP5 in HPA axis dysregulation in our
model (Figure 4D). These findings together with the reductions
in plasma corticosterone and ACTH levels (Figures 4A,B) at
6 months after RUS, implicates a dysfunction in the intrinsic
homeostatic mechanisms regulating the HPA axis and also
highlights the presence of possible molecular abnormalities
in the hypothalamus as a contributing factor underlying this
dysfunction. Previous reports have also suggested a role for
the pituitary gland in dysregulation of HPA axis sensitivity
in PTSD patients (Ströhle et al., 2008; Cooper et al., 2017),
however, a full understanding of the nature of this dysregulation
remains elusive. Further chronic studies involving challenging
the hypothalamus, pituitary and/or adrenal glands after exposure
to our stress exposure paradigm will be needed to explore these
possibilities.
Hypothalamus-pituitary-adrenal axis activation is involved
in negative feedback control of the immune response as a
natural protective mechanism to prevent excessive inflammation
(Gill et al., 2009; Koelsch et al., 2016). The uncontrolled
and excessive activation of HPA axis in stress disorders is
associated with chronic immune system dysregulation (Gill
et al., 2009). Indeed, peripheral inflammation has been reported
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Brain-derived neurotrophic factor and its receptor TrkB are
densely expressed in the hippocampus and their signaling is
involved in a variety of functions including supporting neuronal
survival, growth, and differentiation (Phillips, 2017). The
BDNF/TrkB system has been implicated in the pathophysiology
of a number of psychiatric disorders, such as schizophrenia
(Autry and Monteggia, 2012), depression (Autry and Monteggia,
2012), and PTSD (Grassi-Oliveira et al., 2008; Angelucci
et al., 2014; Dretsch et al., 2016). A single nucleotide
polymorphism in the BDNF gene, causing a valine to methionine
substitution (V66M) is linked to poor working memory, reduced
hippocampal volume (Brooks et al., 2014) and alterations in fear
extinction in humans (Soliman et al., 2010). In animal studies,
V66M was associated with increased anxiety and depressionlike behavior (Chen et al., 2007). In a rat model of PTSD,
exposure to psychosocial stress was linked long-term epigenetic
changes in hippocampal BDNF DNA (Roth et al., 2011). In
addition, several types of stressors, including restraint stress,
social defeat, and electric foot shocks, result in a decrease in
BDNF levels in the hippocampus (Lee and Kim, 2010; Yu
and Chen, 2011). Consistent with our data showing abnormal
passive stress coping behavior in animals exposed to RUS,
BDNF levels were significantly reduced in the hippocampus of
mice exposed to stress (Figure 6D). Given that we did not
observe any impairments in hippocampal-related tasks, such as
spatial learning, and recall of reference memory (Supplementary
Figure S5), and taken together, the lower BDNF levels and the
reduced CA1 volume observed herein, suggest that exposure
to RUS interferes with a unique yet unknown function of the
hippocampus in regulating aspects of fear memory expression
and alterations in stress coping strategies (Figure 8). Regions
such as the prefrontal cortex, amygdala, and hypothalamus
which are associated with these functions, can receive and
project their connections to the hippocampus, and therefore
future studies investigating this complex neurocircuitry may
help elucidate the role played by this critical brain region in
PTSD.
Acute stress exposure and fear learning are associated with
immediate (mins to hrs.) increase in amygdala activity as
detected by imaging studies, and neuroplasticity (increased
NMDA receptors and downstream synaptic signaling partners)
(Yasmin et al., 2016; Balu et al., 2017). We did not examine
the immediate effects (mins to hrs.) of stress on amygdala
activity, however, the reduced expression levels of NMDA
receptors and related neuroplasticity markers observed at the
acute timepoint (Figure 7) may suggest the presence of
compensatory mechanisms to the initial hyperactivity in the
amygdala neurocircuitry. The hypothalamus is rich in neurons
that secrete numerous neuropeptides that regulate several
autonomic functions implicated in regulating neurocircuitry
pathways involved in mood and stress management. We

conducted molecular profiling of regulatory neuropeptides
within the hypothalamus, and observed a significant increase in
Orexin-A levels at 6 months after stress (Figure 5). Orexin-A is a
key regulator of the sleep/wakefulness cycle (Berridge et al., 2009;
Tsujino and Sakurai, 2013). Sleep disturbance and occurrence of
traumatic nightmares is a common feature of PTSD in humans.
A number of studies have drawn a critical link between Orexin
system dysregulation and stress/anxiety disorders (Johnson et al.,
2010, 2012). Orexins are also believed to be an emerging target
for treatment of PTSD (Krystal et al., 2017), however, further
examination of Orexin signaling and circuitry is needed to
understand their role in PTSD pathophysiology. This finding
suggests the suitability of this model as a platform to explore the
role of Orexins in stress disorders.
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